3 / 18
Page 26
Day 1 September 12, 2016
Session Chair
Palayakotai Raghavan
Nanorx Inc, USA
Session Co-Chair
Jerzy Radecki
Polish Academy of Science, Poland
Tracks: 1, 3, 5, 7 & 9
Track 1: Influenza Vaccines: Designs and Developments
Track 3: Influenza: Causes, Symptoms and Treatment
Track 5: Influenza Vaccines : Safety and Effectiveness
Track 7: Advances in Viral Detection and Identification Technologies
Track 9: Host Genetics of Infection and Immunology
Session Introduction
Title:
CiFlu®: Development of a novel subunit influenza vaccine candidate based on the ciliate performance
expression system
Marcus Hartmann,
Cilian AG, Germany
Title:
Global recognition of influenza-like severe respiratory illness
Sherwin Morgan,
University of Chicago Medicine, USA
Title:
Electrochemical immunosensors: Universal tools for rapid detection of viruses
Hanna Radecka,
Polish Academy of Science, Poland
Title:
Electrochemical genosensors based on redox active monolayers: Characterization and applications
Jerzy Radecki,
Polish Academy of Science, Poland
Title:
DIVA tests for avian influenza, which antigen must be chosen
Farhid Hemmatzadeh,
The University of Adelaide, Australia
Title:
Multivalent influenza hemagglutinin promotes the immundominance of non-neutralizing antibody
responses through reptatively constrained orientation
Daniel Lingwood,
The Ragon Institute of MGH, MIT and Harvard University, USA
Title:
Challenges in development of chitosan-based adjuvants for influenza vaccines
Yuri M Vasiliev,
Mechnikov Research Institute of Vaccines & Sera, Russia